Abstract
Introduction

27
Single-cell RNA-Sequencing (scRNA-seq) enable precise characterization of gene expression 28 levels, which harbour variation in expression associated with both technical (e.g., biases in which some of the sources of variation are 'wanted' and are highly correlated with each other.
61
To fill this gap, we developed a robust and iterative SVA-based statistical framework: sources, which is a limitation of existing SVA-based methods. Second, it enables assessing 66 the significance of each detected factor for explaining the unmodeled variation in the data.
67
Third, it delivers a set of genes that are significantly associated with the detected hidden 68 source. Application of IA-SVA for scRNA-seq data analyses is diverse including the 69 detection of "unwanted" variation due to cell contamination or "wanted" variation associated 70 with rare cell types ( Figure 1B ). In simulation studies we showed that IA-SVA i) provides 71 high statistical power in detecting hidden factors; ii) controls Type I error rate at the nominal 72 level ( = 0.05); iii) delivers high accuracy in estimating hidden factors. We evaluated the 73 efficacy of IA-SVA on scRNA-seq data from human pancreatic islets and brain cells and
74
showed that IA-SVA is effective in capturing heterogeneity associated with both technical
75
(e.g., doublet cells) and biological sources (e.g., differences in cell types or cell-cycle stages). 
80
Results
81
Benchmarking IA-SVA on simulated data.
82
To assess and compare the detection power, Type I error rate, and the accuracy of hidden uncovered alternative marker genes associated with alpha, beta and ductal cells ( Figure 4B ).
194
These genes were annotated with diabetes and insulin processing related GO terms and 195 pathways (Supplementary Table S4 between known factors (i.e., patient ID) and the hidden factor (i.e., cell types).
227
We applied IA-SVA on this complex data, while accounting for known factors (i.e., factor is 'wanted' (e.g., cell types) and is highly correlated with known factors, removing the 293 known factors will also diminish the ability to detect the wanted hidden factor and the genes 294 associated with this factor (e.g., marker genes for different cell types). Indeed, our analyses 295 using islet cells emphasized the importance of properly adjusting the data for known factors 296 prior to further analyses, such as data visualization (e.g., tSNE) to prevent spurious clustering 297 of cells due to the confounding factors ( Figure 4E the analyses of complex data (i.e., data with multiple confounding and correlated factors).
310
With the increasing amount of single cell studies and the increasing complexity of human 311 cohorts, IA-SVA will serve as an effective statistical framework specifically designed to 312 handle unique challenges of scRNA-seq data analyses.
313
Methods
314
IA-SVA framework.
315
We model the log-transformed sequencing read counts for m cells and n genes (i.e., !×! ) as 316 a combination of known and unknown variables as follows: PC1 to be used as a surrogate variable (SV) for the hidden factor. In the next iteration, IA-
353
SVA uses this SV as an additional known factor to identify further significant hidden factors.
354
The iterative procedure of IA-SVA is composed of six major steps as summarized in Figure   355 1A and below: further evaluated to discover novel biology from these complex datasets.
379
Assessing the significance of hidden factors.
380
To test the significance of the contribution of a hidden factor estimate (i.e., PC1 obtained in
381
Step 2) to the residual variation, we used the permutation based significance test as scRNA-seq data simulation.
401
To eliminate the potential bias in data simulations and make simulation studies more stemming from a smaller fraction of genes (10%) and especially when factors are correlated. 
